Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea

European Respiratory Journal

Volumn 39, Issue 5, 2012, Pages 1136-1143

  Bonsignore, Maria R ^a   Esquinas, Cristina ^b,c   Barcelo, Antonia ^e   Sanchez de la Torre, Manuel ^d,f   Paternó, Alessandra ^a   Duran Cantolla, Joaquin ^g   Marín, José M ^h   Barbé, Ferran ^c,d  

^a UNIVERSITY OF PALERMO   (Italy)

^b Hospital Santa Maria   (Spain)

^c HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^d UNIVERSITY OF LLEIDA   (Spain)

^e HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

^g UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^h HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Epidemiology; Intermittent hypoxia; Metabolism; Sex

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; OXYGEN; TRIACYLGLYCEROL;

ADULT; AGE; ANTHROPOMETRIC PARAMETERS; APNEA HYPOPNEA INDEX; ARTERIAL OXYGEN SATURATION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DAYTIME SOMNOLENCE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; EPWORTH SLEEPINESS SCALE; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTATIC MODEL ASSESSMENT INDEX; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NATIONAL CHOLESTEROL EDUCATION PROGRAM ADULT TREATMENT PANEL III CRITERIA; NECK CIRCUMEFERENCE; OBESITY; PREVALENCE; PRIORITY JOURNAL; RELIABILITY; SEX DIFFERENCE; SLEEP APNEA SYNDROME; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAKEFULNESS;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OXYGEN; PREVALENCE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SLEEP APNEA, OBSTRUCTIVE; SLEEP STAGES;

EID: 84860345856     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00151110     Document Type: Article

References (40)

1. McArdle N, Hillman D, Beilin L, et al. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 2007; 175: 190-195. (Pubitemid 46115091)
2. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-1053. (Pubitemid 40386782)
3. Doherty LS, Kiely JL, Swan V, et al. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005; 127: 2076-2084.
4. Lévy P, Bonsignore MR, Eckel J. Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 2009; 34: 243-260.
5. Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol 2009; 106: 1538-1544.
6. Barceló A, Barbé F, Llompart E, et al. Effects of obesity on Creactive protein level and metabolic disturbances in male patients with obstructive sleep apnea. Am J Med 2004; 117: 118-121. (Pubitemid 38953732)
7. Gruber A, Horwood F, Sithole J, et al. Obstructive sleep apnea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 2006; 5: 22-29.
8. Sharma SK, Kumpawat S, Goel A, et al. Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 2007; 8: 12-17. (Pubitemid 46044133)
9. Otake K, Sasanabe R, Hasegawa R, et al. Glucose intolerance in Japanese patients with obstructive sleep apnea. Intern Med 2009; 48: 1863-1868.
10. Lorenzo C, Okoloise M, Williams K, et al. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care 2003; 26: 3153-3159. (Pubitemid 37339513)
11. Ho JS, Cannaday JJ, Barlow CE, et al. Relation of the number of metabolic syndrome risk factors with all-cause and cardiovascular mortality. Am J Cardiol 2008; 102: 689-692.
12. Simmons RK, Alberti KG, Gale EA, et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 2010; 53: 600-605.
13. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
14. Coughlin SR, Mawdsley L, Mugarza JA, et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25: 735-741. (Pubitemid 38647933)
15. Sasanabe R, Banno K, Otake K, et al. Metabolic syndrome in Japanese patients with obstructive sleep apnea syndrome. Hypertens Res 2006; 29: 315-322. (Pubitemid 43965112)
16. Peled N, Kassirer M, Shitrit D, et al. The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respir Med 2007; 101: 1696-1701. (Pubitemid 46947878)
17. Parish JM, Adam T, Facchiano L. Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med 2007; 3: 467-472. (Pubitemid 47378249)
18. Agrawal S, Sharma SK, Sreenivas V, et al. Stepped approach for prediction of syndrome Z in patients attending sleep clinic: a north Indian hospital-based study. Sleep Breath 2011; [Epub ahead of print DOI: 10.1007/s11325-011-0548-3].
19. Akahoshi T, Uematsu A, Akashiba T, et al. Obstructive sleep apnoea is associated with risk factors comprising the metabolic syndrome. Respirology 2010; 15: 1122-1126.
20. Onat A, Hergenç G, Uyarel H, et al. Obstructive sleep apnea syndrome is associated with metabolic syndrome rather than insulin resistance. Sleep Breath 2007; 11: 23-30. (Pubitemid 46485246)
21. Kapur VK, Resnick HE, Gottlieb DJ, et al. Sleep disordered breathing and hypertension: does self-reported sleepiness modify the association? Sleep 2008; 31: 1127-1132.
22. Lombardi C, Parati G, Cortelli P, et al. Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders. J Sleep Res 2008; 17: 263-270.
23. Ronksley PE, Hemmelgarn BR, Heitman SJ, et al. Obstructive sleep apnoea is associated with diabetes in sleepy subjects. Thorax 2009; 64: 834-839.
24. Barceló A, Barbé F, de la Peña M, et al. Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax 2008; 63: 946-950.
25. Nena E, Steiropoulos P, Papanas N, et al. Sleepiness as a marker of glucose deregulation in obstructive sleep apnea. Sleep Breath 2011; [Epub ahead of print DOI: 10.1007/s11325-010-0472-y].
26. Drager LF, Lopes HF, Maki-Nunes C, et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One 2010; 5: e12065.
27. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
28. Kono M, Tatsumi K, Saibara T, et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 2007; 131: 1387-1392. (Pubitemid 46762343)
29. Lam JC, Lam B, Lam CL, et al. Obstructive sleep apnea and the metabolic syndrome in community-based Chinese adults in Hong Kong. Respir Med 2006; 100: 980-987.
30. Chin K, Oga T, Takahashi K, et al. Associations between obstructive sleep apnea, metabolic syndrome, and sleep duration, as measured with an actigraph, in an urban male working population in Japan. Sleep 2010; 33: 89-95.
31. Nieto FJ, Peppard PE, Young TB. Sleep disordered breathing and metabolic syndrome. Wisc Med J 2009; 108: 263-265.
32. Theorell-Haglöw J, Berne C, Janson C, et al. The role of obstructive sleep apnea in metabolic syndrome: a population-based study in women. Sleep Med 2011; 12: 329-334.
33. Sundström J, Vallhagen E, Risérus U, et al. Risk associated with the metabolic syndrome versus the sum of its individual components. Diabetes Care 2006; 29: 1673-1674. (Pubitemid 44127603)
34. Baldassarre D, Werba JP, Castelnuovo S, et al. The metabolic syndrome predicts carotid intima-media thickness no better than the sum of individual risk factors in a lipid clinic population. Atherosclerosis 2010; 210: 214-219.
35. Bayturan O, Tuzcu EM, Lavoie A, et al. The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis. Arch Intern Med 2010; 170: 478-484.
36. Drager LF, Li J, Reinke C, et al. Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity (Silver Spring) 2011; 19: 2167-2174.
37. Lin QC, Zhang XB, Chen GP, et al. Obstructive sleep apnea is associated with some components of metabolic syndrome in nonobese adults. Sleep Breath 2011; [Epub ahead of print DOI: 10.1007/s11325-011-0544-7].
38. Gasa M, Salord N, Fortuna AM, et al. Obstructive sleep apnoea and metabolic impairment in severe obesity. Eur Respir J 2011; 38: 1089-1097.
39. Preis SR, Massaro JM, Hoffmann U, et al. Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study. J Clin Endocrinol Metab 2010; 95: 3701-3710.
40. Drager LF, Bortolotto LA, Maki-Nunes C, et al. The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis 2010; 208: 490-495.